Abstract
The clinical presentation of severe infection with generalized inflammation is similar, if not identical, to systemic inflammation induced by sterile tissue injury. Novel models and unbiased technologies are urgently needed for biomarker identification and disease profiling in sepsis. Here we briefly review the article of Kamisoglu and colleagues in this issue of Critical Care on comparing metabolomics data from different studies to assess whether responses elicited by endotoxin recapitulate, at least in part, those seen in clinical sepsis.
Similar content being viewed by others
Abbreviations
- CAPSOD:
-
Community acquired pneumonia and sepsis outcome and diagnostics
- GC:
-
Gas chromatography
- LC:
-
Liquid chromatography
- MS:
-
Mass spectrometry
- NMR:
-
Nuclear magnetic resonance
- SIRS:
-
Systemic inflammatory response syndrome
- TLR:
-
Toll like receptor
References
Kamisoglu K, Haimovich B, Calvano SE, Coyle SM, Corbett SA, Langley RJ, et al. Human metabolic response to systemic inflammation: assessment of the concordance between experimental endotoxemia and clinical cases of sepsis/SIRS. Crit Care. 2015;19:71.
Artenstein AW, Higgins TL, Opal SM. Sepsis and scientific revolutions. Crit Care Med. 2013;41:2770–2.
Banoei MM, Donnelly SJ, Mickiewicz B, Weljie A, Vogel HJ, Winston BW. Metabolomics in critical care medicine: a new approach to biomarker discovery. Clin Invest Med. 2014;37:E363–76.
Sriyudthsak K, Shiraishi F, Hirai MY. Identification of a metabolic reaction network from time-series data of metabolite concentrations. PLoS One. 2013;8:e51212.
Lacy P. Metabolomics of sepsis-induced acute lung injury: a new approach for biomarkers. Am J Physiol Lung Cell Mol Physiol. 2011;300:L1–3.
Kaddurah-Daouk R, Kristal BS, Weinshilboum RM. Metabolomics: a global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol. 2008;48:653–83.
Zheng Y, Yu B, Alexander D, Mosley TH, Heiss G, Nettleton JA, et al. Metabolomics and incident hypertension among blacks: the atherosclerosis risk in communities study. Hypertension. 2013;62:398–403.
Arakawa K, Tomita M. Merging multiple omics datasets in silico: statistical analyses and data interpretation. Methods Mol Biol. 2013;985:459–70.
Bartel J, Krumsiek J, Theis FJ. Statistical methods for the analysis of high-throughput metabolomics data. Comput Struct Biotechnol J. 2013;4:e201301009.
Oresic M, Hyotylainen T, Herukka SK, Sysi-Aho M, Mattila I, Seppanan-Laakso T, et al. Metabolome in progression to Alzheimer’s disease. Transl Psychiatry. 2011;1:e57.
Bowling FG, Thomas M. Analyzing the metabolome. Methods Mol Biol. 2014;1168:31–45.
Schmerler D, Neugebauer S, Ludewig K, Bremer-Streck S, Brunkhorst FM, Kiehntopf M. Targeted metabolomics for discrimination of systemic inflammatory disorders in critically ill patients. J Lipid Res. 2012;53:1369–75.
The Human Metabolome Project (HMDB). http://www.hmdb.ca/. Accessed 18 May 2015.
Yoon SH, Han MJ, Jeong H, Lee CH, Xia XX, Lee DH, et al. Comparative multi-omics systems analysis of Escherichia coli strains B and K-12. Genome Biol. 2012;13:R37.
Author information
Authors and Affiliations
Corresponding author
Additional information
Competing interests
The author declares that she has no competing interests.
See related research by Kamisoglu et al., http://ccforum.com/content/19/1/71
Rights and permissions
About this article
Cite this article
dos Santos, C.C. Shedding metabo‘light’ on the search for sepsis biomarkers. Crit Care 19, 277 (2015). https://doi.org/10.1186/s13054-015-0969-7
Published:
DOI: https://doi.org/10.1186/s13054-015-0969-7